Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
85.55 USD | -0.16% |
|
+13.36% | +10.02% |
Jun. 18 | Jordan gets 5 participants in 120,000 metric ton barley tender, traders say | RE |
Jun. 18 | CICC Adjusts Price Target on Bunge Global to $92 From $85, Maintains Outperform Rating | MT |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.21 | 6.21 | 6.62 | 8.19 | 3.89 | |||||
Return on Total Capital | 6.56 | 9.91 | 10.46 | 12.34 | 5.48 | |||||
Return On Equity % | 17.86 | 29.23 | 18.47 | 21.46 | 10.44 | |||||
Return on Common Equity | 21.15 | 33.08 | 19.87 | 22.35 | 10.95 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 6.73 | 6.06 | 5.83 | 8.15 | 6.28 | |||||
SG&A Margin | 3.22 | 2.08 | 1.98 | 2.56 | 3.25 | |||||
EBITDA Margin % | 4.46 | 4.7 | 4.42 | 6.25 | 3.82 | |||||
EBITA Margin % | 3.53 | 4.07 | 3.87 | 5.6 | 3.01 | |||||
EBIT Margin % | 3.41 | 3.99 | 3.81 | 5.5 | 2.94 | |||||
Income From Continuing Operations Margin % | 2.81 | 3.66 | 2.5 | 3.92 | 2.24 | |||||
Net Income Margin % | 2.77 | 3.51 | 2.39 | 3.77 | 2.14 | |||||
Net Avail. For Common Margin % | 2.71 | 3.46 | 2.39 | 3.77 | 2.14 | |||||
Normalized Net Income Margin | 2 | 2.23 | 2.03 | 3.22 | 1.39 | |||||
Levered Free Cash Flow Margin | -5.5 | 2.94 | 1.12 | 3.03 | 0.65 | |||||
Unlevered Free Cash Flow Margin | -5.1 | 3.19 | 1.5 | 3.58 | 1.21 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.97 | 2.49 | 2.78 | 2.38 | 2.11 | |||||
Fixed Assets Turnover | 8.65 | 13.07 | 14.85 | 11.78 | 9.11 | |||||
Receivables Turnover (Average Receivables) | 22.36 | 26.28 | 24.73 | 21.97 | 22.41 | |||||
Inventory Turnover (Average Inventory) | 6.33 | 7.12 | 7.33 | 6.8 | 7.04 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.47 | 1.77 | 1.75 | 2.13 | 2.15 | |||||
Quick Ratio | 0.27 | 0.47 | 0.47 | 0.75 | 0.88 | |||||
Operating Cash Flow to Current Liabilities | -0.32 | -0.31 | -0.58 | 0.43 | 0.26 | |||||
Days Sales Outstanding (Average Receivables) | 16.37 | 13.89 | 14.76 | 16.62 | 16.33 | |||||
Days Outstanding Inventory (Average Inventory) | 57.86 | 51.24 | 49.81 | 53.68 | 51.96 | |||||
Average Days Payable Outstanding | 24.6 | 22.11 | 24.88 | 27.49 | 24.03 | |||||
Cash Conversion Cycle (Average Days) | 49.63 | 43.02 | 39.69 | 42.82 | 44.26 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 122.42 | 83.11 | 56.46 | 48.72 | 65.02 | |||||
Total Debt / Total Capital | 55.04 | 45.39 | 36.08 | 32.76 | 39.4 | |||||
LT Debt/Equity | 76.03 | 64.5 | 38.21 | 39.32 | 48.31 | |||||
Long-Term Debt / Total Capital | 34.18 | 35.23 | 24.42 | 26.44 | 29.27 | |||||
Total Liabilities / Total Assets | 72.01 | 65.55 | 59.48 | 53.43 | 56.03 | |||||
EBIT / Interest Expense | 5.33 | 9.71 | 6.36 | 6.34 | 3.32 | |||||
EBITDA / Interest Expense | 10.15 | 17.84 | 11.58 | 9.74 | 7.53 | |||||
(EBITDA - Capex) / Interest Expense | 8.78 | 16.2 | 10.21 | 7.56 | 4.61 | |||||
Total Debt / EBITDA | 3.01 | 1.57 | 1.2 | 1.15 | 2.01 | |||||
Net Debt / EBITDA | 2.75 | 1.25 | 0.94 | 0.61 | 0.94 | |||||
Total Debt / (EBITDA - Capex) | 3.48 | 1.73 | 1.37 | 1.48 | 3.28 | |||||
Net Debt / (EBITDA - Capex) | 3.18 | 1.37 | 1.07 | 0.78 | 1.53 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 0.64 | 42.87 | 13.66 | -11.44 | -10.8 | |||||
Gross Profit, 1 Yr. Growth % | 25.22 | 28.65 | 9.35 | 25.56 | -31.28 | |||||
EBITDA, 1 Yr. Growth % | 27.91 | 54.96 | 6.72 | 27.63 | -45.14 | |||||
EBITA, 1 Yr. Growth % | 53.63 | 70.71 | 8.14 | 30.71 | -51.69 | |||||
EBIT, 1 Yr. Growth % | 57.59 | 73.33 | 8.61 | 30.41 | -52.23 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -190.24 | 86.01 | -22.57 | 39.27 | -49.17 | |||||
Net Income, 1 Yr. Growth % | -189.45 | 81.48 | -22.52 | 39.32 | -49.31 | |||||
Normalized Net Income, 1 Yr. Growth % | 140.57 | 65.17 | 3.78 | 33.71 | -61.47 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -182.58 | 76.75 | -22.94 | 41.48 | -46.27 | |||||
Accounts Receivable, 1 Yr. Growth % | 4.64 | 37.7 | 8.47 | -8.38 | -17.13 | |||||
Inventory, 1 Yr. Growth % | 42.36 | 17.55 | 0.52 | -14.28 | -9.67 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -5.78 | -5 | 5.21 | 17.8 | 13.15 | |||||
Total Assets, 1 Yr. Growth % | 29.14 | 0.69 | 3.19 | 3.22 | -1.86 | |||||
Tangible Book Value, 1 Yr. Growth % | 5.83 | 42.21 | 38.42 | 18.7 | -8.28 | |||||
Common Equity, 1 Yr. Growth % | 2.99 | 29.75 | 32.17 | 17.64 | -8.64 | |||||
Cash From Operations, 1 Yr. Growth % | 337.62 | -18.16 | 91.74 | -159.61 | -42.56 | |||||
Capital Expenditures, 1 Yr. Growth % | -30.34 | 9.32 | 39.1 | 102.16 | 22.64 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -563.65 | -175.21 | -56.44 | 149.78 | -80.54 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -400.36 | -188.1 | -46.61 | 118.33 | -69.55 | |||||
Dividend Per Share, 1 Yr. Growth % | 0 | 3.75 | 15.66 | 8.85 | 4.11 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -4.86 | 19.91 | 27.43 | 0.33 | -11.12 | |||||
Gross Profit, 2 Yr. CAGR % | 10.62 | 27.04 | 18.61 | 16.38 | -5.85 | |||||
EBITDA, 2 Yr. CAGR % | 11.64 | 39.02 | 26.81 | 15.66 | -15.66 | |||||
EBITA, 2 Yr. CAGR % | 26.92 | 59.43 | 33.48 | 17.67 | -19.81 | |||||
EBIT, 2 Yr. CAGR % | 28.14 | 62.62 | 34.7 | 17.77 | -20.08 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 105.08 | 29.56 | 20.01 | 3.85 | -15.86 | |||||
Net Income, 2 Yr. CAGR % | 107.08 | 27.41 | 18.58 | 3.89 | -15.96 | |||||
Normalized Net Income, 2 Yr. CAGR % | 74.26 | 96.18 | 29.12 | 16.23 | -25.66 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 121.69 | 20.82 | 16.71 | 4.42 | -12.81 | |||||
Accounts Receivable, 2 Yr. CAGR % | 3.59 | 20.04 | 22.22 | -0.31 | -12.86 | |||||
Inventory, 2 Yr. CAGR % | 10.53 | 29.36 | 9.9 | -7.17 | -12.01 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -5.52 | -5.39 | -0.02 | 11.33 | 15.45 | |||||
Total Assets, 2 Yr. CAGR % | 10.35 | 14.03 | 1.94 | 3.21 | 0.65 | |||||
Tangible Book Value, 2 Yr. CAGR % | 2.49 | 22.68 | 40.31 | 28.18 | 4.34 | |||||
Common Equity, 2 Yr. CAGR % | -0.95 | 15.59 | 30.95 | 24.69 | 3.67 | |||||
Cash From Operations, 2 Yr. CAGR % | 67.26 | 89.25 | 25.27 | 6.91 | -41.48 | |||||
Capital Expenditures, 2 Yr. CAGR % | -13.96 | -12.74 | 23.31 | 67.69 | 57.46 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 2.18K | 88.52 | -42.37 | 2 | -28.75 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 219 | 64.19 | -30.9 | 6.18 | -17.21 | |||||
Dividend Per Share, 2 Yr. CAGR % | 2.06 | 1.86 | 9.54 | 12.07 | 6.46 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -3.3 | 8.95 | 17.79 | 12.87 | -3.53 | |||||
Gross Profit, 3 Yr. CAGR % | 15.66 | 16.33 | 20.85 | 20.34 | -2.36 | |||||
EBITDA, 3 Yr. CAGR % | 20.3 | 23.37 | 27.29 | 26.32 | -9.97 | |||||
EBITA, 3 Yr. CAGR % | 44.82 | 38.45 | 40.08 | 31.64 | -12.73 | |||||
EBIT, 3 Yr. CAGR % | 46.18 | 39.98 | 42.15 | 32.33 | -12.82 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 88.48 | 98.51 | 9.13 | 26.12 | -18.16 | |||||
Net Income, 3 Yr. CAGR % | 92.71 | 98.17 | 7.95 | 25.12 | -18.21 | |||||
Normalized Net Income, 3 Yr. CAGR % | 54.96 | 68.95 | 58.66 | 32.67 | -19.56 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 105.43 | 105.57 | 4 | 24.44 | -16.32 | |||||
Accounts Receivable, 3 Yr. CAGR % | 5.61 | 13.9 | 16.05 | 11.02 | -6.26 | |||||
Inventory, 3 Yr. CAGR % | 12.23 | 12.82 | 19.8 | 1.16 | -8.01 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -4.38 | -5.34 | -1.98 | 5.6 | 11.93 | |||||
Total Assets, 3 Yr. CAGR % | 7.82 | 7.03 | 10.3 | 2.36 | 1.49 | |||||
Tangible Book Value, 3 Yr. CAGR % | -8.79 | 14.32 | 27.72 | 32.7 | 14.65 | |||||
Common Equity, 3 Yr. CAGR % | -5.91 | 8.37 | 20.87 | 26.35 | 12.41 | |||||
Cash From Operations, 3 Yr. CAGR % | 21.43 | 31.8 | 90.08 | -2.2 | -13.09 | |||||
Capital Expenditures, 3 Yr. CAGR % | -18 | -6.81 | 1.93 | 45.4 | 51.08 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 163.74 | 634.91 | 15.68 | -7.43 | -41.51 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 94.15 | 108.78 | 12.91 | 0.28 | -30.21 | |||||
Dividend Per Share, 3 Yr. CAGR % | 4.35 | 2.62 | 6.27 | 9.31 | 9.35 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -0.96 | 6.75 | 7.98 | 5.41 | 5.24 | |||||
Gross Profit, 5 Yr. CAGR % | 0.5 | 8.27 | 16.83 | 16.35 | 8.48 | |||||
EBITDA, 5 Yr. CAGR % | 0 | 10.66 | 22.86 | 20.23 | 7.12 | |||||
EBITA, 5 Yr. CAGR % | 1.91 | 15.7 | 40.17 | 29.73 | 11.06 | |||||
EBIT, 5 Yr. CAGR % | 1.64 | 15.86 | 41.48 | 30.64 | 11.87 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 9.06 | 22.8 | 57.34 | 53.19 | -1.65 | |||||
Net Income, 5 Yr. CAGR % | 7.68 | 22.77 | 58.69 | 53.06 | -2.34 | |||||
Normalized Net Income, 5 Yr. CAGR % | 4.29 | 18.45 | 43.73 | 47.62 | 16.6 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 9.77 | 21.87 | 63.85 | 56.78 | -3.08 | |||||
Accounts Receivable, 5 Yr. CAGR % | 2.35 | 8.15 | 11.96 | 7.99 | 3.48 | |||||
Inventory, 5 Yr. CAGR % | 9.94 | 12.05 | 11.29 | 4.81 | 5.89 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | -0.4 | -2.86 | -2.66 | 1 | 4.65 | |||||
Total Assets, 5 Yr. CAGR % | 5.72 | 4.42 | 5.43 | 5.49 | 6.33 | |||||
Tangible Book Value, 5 Yr. CAGR % | -3.16 | 1.09 | 8.35 | 19.67 | 17.8 | |||||
Common Equity, 5 Yr. CAGR % | -1.33 | 1.58 | 7.39 | 14.63 | 13.67 | |||||
Cash From Operations, 5 Yr. CAGR % | 42.11 | 45.36 | 22.95 | 21.22 | 18.65 | |||||
Capital Expenditures, 5 Yr. CAGR % | -10.87 | -12.64 | -3.46 | 17.88 | 21.3 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 19.63 | 17.39 | 43.54 | 233.56 | -6.59 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 14.1 | 15.34 | 28.44 | 59.31 | -1.73 | |||||
Dividend Per Share, 5 Yr. CAGR % | 6.79 | 5.34 | 6.4 | 6.35 | 6.34 |
- Stock Market
- Equities
- BG Stock
- Financials Bunge Global SA
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions